Chronic wounds and the medical biofilm paradigm

Journal of Wound Care

Volumn 19, Issue 2, 2010, Pages 45-53

  Wolcott, R D ^a   Rhoads, D D ^a   Bennett, M E ^a   Wolcott, B M ^a   Gogokhia, L ^a   Costerton, J W ^b   Dowd, S E ^c  

^a Southwest Regional Wound Care Center Lubbock   (United States)

^b Center for Genomic Sciences   (United States)

^c Research and Testing Laboratory   (United States)

Author keywords

Acute planktonic; Chronic biofilm infection; Clinical indicators; Therapeutic strategies

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BIOFILM; CHRONIC DISEASE; FEMALE; HUMAN; MICROBIOLOGY; ULCER; VARICOSIS; WOUND INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BIOFILMS; CHRONIC DISEASE; FEMALE; HUMANS; ULCER; VARICOSE ULCER; WOUND INFECTION;

EID: 77951224305     PISSN: 09690700     EISSN: None     Source Type: Journal    
DOI: 10.12968/jowc.2010.19.2.46966     Document Type: Article

References (121)

1. Lowe, A. M., Yansouni, C. P., Behr, M. A. Causality and gastrointestinal infections: Koch, Hill, and Crohn's Lancet Infect Dis 2008;8: s11, 720-726.
2. Donlan, R. M., Costerton, J. W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15: s2, 167-193.
3. Bhinu, V. S. Insight into biofilm-associated microbial life. J Mol Microbiol Biotechnol 2005;10: s1, 15-21.
4. Leid, J. G., Willson, C. J., Shirtliff, M. E. et al. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol 2005;175: s11, 7512-7518.
5. Fux, C. A., Costerton, J. W., Stewart, P. S., Stoodley, P. Survival strategies of infectious biofilms. Trends Microbiol 2005;13:34-40.
6. Wolcott, R. D., Rhoads, D. D., Dowd, S. E. Biofilms and chronic wound inflammation. J. Wound. Care 2008;17:333-341
7. Ladwig, G. P., Robson, M. C., Liu, R. et al. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen 2002;10: s1, 26-37.
8. Brandner, J. M., Zacheja, S., Houdek, P. et al. Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation into an ex vivo wound-healing model. Diabetes Care 2008;31: s1, 114-120.
9. Trengove, N. J., Bielefeldt-Ohmann, H., Stacey, M. C. Mitogenic activity and cytokine levels in nonhealing and healing chronic leg ulcers. Wound Repair Regen 2000;8: s1, 13-25.
10. Ambrosch, A., Lobmann, R., Pott, A., Preissler, J. Interleukin-6 concentrations in wound fluids rather than serological markers are useful in assessing bacterial triggers of ulcer inflammation. Int Wound J 2008;5: s1, 99-106.
11. Kimura, F., Shimizu, H., Yoshidome, H. et al. Increased plasma levels of IL-6 and IL-8 are associated with surgical site infection after pancreaticoduodenectomy. Pancreas 2006;32: s2, 178-185.
12. James, G. A., Swogger, E., Wolcott, R. et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16: s1, 37-44.
13. Costerton, J. W., Stewart, P. S., Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 1999;284: s5418, 1318-1322.
14. Harrison-Balestra, C., Cazzaniga, A. L., Davis, S. C., Mertz, P. M. A woundisolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg 2003;29: s6, 631-635.
15. Schaber, J. A., Triffo, W. J., Suh, S. J. et al. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun 2007;75: s8, 3715-3721.
16. Schierle, C. F., De la Garza, M. et al. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen 2009;17: s3, 354-359.
17. Jaryszak, E. M., Sampson, E. M., Antonelli, P. J. Biofilm formation by Pseudomonas aeruginosa on ossicular reconstruction prostheses. Am J Otolaryngol 2009;30: s6, 367-370.
18. Dowd, S. E., Sun, Y., Secor, P. R. et al. Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing. BMC Microbiol 2008;8, s43.
19. Dowd, S. E., Wolcott, R. D., Sun, Y. et al. Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 2008;3: s10, e3326.
20. Wolcott, R. D., Gontcharova, V., Sun, Y. et al. Bacterial diversity in surgical site infections: not just aerobic cocci any more. J Wound Care 2009;18: s8, 317-323.
21. Wolcott, R. D., Gontcharova, V., Sun, Y., Dowd, S. E. Evaluation of the bacterial diversity among and within individual venous leg ulcers using bacterial tag-encoded FLX and titanium amplicon pyrosequencing and metagenomic approaches. BMC Microbiol 2009;9:226.
22. Rickard, A. H., Colacino, K. R., Manton, K. M. et al. Production of cell-cell signalling molecules by bacteria isolated from human chronic wounds. J Appl Microbiol 2009; Sep. 21. [Epub ahead of print]
23. Rickard, A. H., Gilbert, P., High, N. J. et al. Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol 2003;11: s2, 94-100.
24. Wolcott, R. D., Rhoads, D. D. A study of biofilmbased wound management in subjects with critical limb ischaemia. J Wound Care 2008;17: s4, 145-154.
25. Abraham, W. R. Controlling biofilms of gram-positive pathogenic bacteria. Curr Med Chem 2006;13: s13, 1509-1524.
26. Gardner, S. E., Frantz, R. A., Doebbeling, B. N. The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound. Repair Regen 2001;9:178-186.
27. Chandrasekhara, P. K., Jayachandran, N. V., Thomas, J. et al. Successful treatment of pyoderma gangrenosum associated with juvenile idiopathic arthritis with a combination of topical tacrolimus and oral prednisolone. Clin Rheumatol 2009;28:489-490.
28. Meltzer, D. D., Pels, S., Payne, W. G. et al. Decreasing amputation rates in patients with diabetes mellitus: an outcome study. J Am Podiatr Med Assoc 2002;92: s8, 425-428.
29. Colsky, A. S., Kirsner, R. S., Kerdel, F. A. Microbiologic evaluation of cutaneous wounds in hospitalized dermatology patients. Ostomy Wound Manage 1998;44:40-46.
30. Parahitiyawa, N. B., Scully, C., Leung, W. K. et al. Exploring the oral bacterial flora: current status and future directions. Oral Dis 2009 [Epub ahead of print]
31. Stoodley, P., Kathju, S., Hu, F. Z. et al. Molecular and imaging techniques for bacterial biofilms in joint arthroplasty infections Clin Orthop Relat Res 2005;437:31-40.
32. Davies, C. E., Hill, K. E., Wilson, M. J. et al. Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and nonhealing chronic venous leg ulcers. J Clin Microbiol 2004;42: s8, 3549-3557.
33. Davies, C. E., Wilson, M. J., Hill, K. E. et al. Use of molecular techniques to study microbial diversity in the skin: chronic wounds reevaluated. Wound Repair Regen 2001;9:332-340.
34. Rantakokko-Jalava, K., Nikkari, S., Jalava, J. et al. Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol 2000;38:32-39.
35. Kotilainen, P., Jalava, J., Meurman, O. et al. Diagnosis of meningococcal meningitis by broad-range bacterial PCR with cerebrospinal fluid. J Clin Microbiol 1998;36: s8, 2205-2209.
36. Augustin, J. C., Carlier, V. Lessons from the organization of a proficiency testing program in food microbiology by interlaboratory comparison: analytical methods in use, impact of methods on bacterial counts and measurement uncertainty of bacterial counts. Food Microbiol 2006;23: s1, 1-38.
37. Cunha, M. L., Sinzato, Y. K., Silveira, L. V. Comparison of methods for the identification of coagulase-negative staphylococci. Mem Inst Oswaldo Cruz 2004;99:855-860.
38. Hussain, Z., Stoakes, L., Stevens, D. L. et al. Comparison of the MicroScan system with the API Staph-Ident system for species identification of coagulase-negative staphylococci. J Clin Microbiol 1986;23: s1, 126-128.
39. Moore, D. F., Zhowandai, M. H., Ferguson, D. M. et al. Comparison of 16S rRNA sequencing with conventional and commercial phenotypic techniques for identification of enterococci from the marine environment. J Appl Microbiol 2006;100:1272-1281.
40. Ecker, D. J., Massire, C., Blyn, L. B. et al. Molecular genotyping of microbes by multilocus PCR and mass spectrometry: a new tool for hospital infection control and public health surveillance. Methods Mol Biol 2009;551:71-87.
41. Ecker, D. J., Sampath, R., Massire, C. et al. Ibis T5000: a universal biosensor approach for microbiology. Nat Rev Microbiol 2008;6: s7, 553-558.
42. Deng, J., Zheng, Y., Zhao, R. et al. Culture versus polymerase chain reaction for the etiologic diagnosis of community-acquired pneumonia in antibioticpretreated pediatric patients. Pediatr Infect Dis J 2009;28:53-55.
43. Parsek, M. R., Singh, P. K. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003;57:677-701.
44. Digestive Disease Statistics. National Digestive Diseases Information Clearinghouse 2005. Available from: URL:http://digestive.niddk.nih.gov/ statistics/statistics.htm.
45. Nealon, W. H., Urrutia, F., Fleming, D., Thompson, J. C. The economic burden of gallstone lithotripsy. Will cost determine its fate? Ann Surg 1991;213: s6, 645-649.
46. Stewart, L., Griffiss, J. M., Jarvis, G. A., Way, L. W. Gallstones containing bacteria are biofilms: bacterial slime production and ability to form pigment solids determines infection severity and bacteremia. J Gastrointest Surg 2007;11: s8, 977-983.
47. Swidsinski, A., Lee, S. P. The role of bacteria in gallstone pathogenesis. Front Biosci 2001;6: E93-103.
48. Bassi A, Dodd S, Williamson P, Bodger K. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study. Gut 2004;53: s10, 1471-1478.
49. HCUP Nationwide Inpatient Samples (NIS). Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality, 2005. Available from: http://hcupnet.ahrq.gov.
50. Jess, T., Loftus, E. V., Jr., Harmsen, W. S. et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut 2006;55: s9, 1248-1254.
51. Kim, S. C., Ferry, G. D. Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology 2004;126: s6, 1550-1560.
52. Swidsinski, A., Weber, J., Loening-Baucke, V. et al. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005;43: s7, 3380-3389.
53. Coticchia, J. M., Sugawa, C., Tran, V. R. et al. Presence and density of Helicobacter pylori biofilms in human gastric mucosa in patients with peptic ulcer disease. J Gastrointest Surg 2006;10: s6, 883-889.
54. Kong, S. X., Hatoum, H. T., Zhao, S. Z. et al. Prevalence and cost of hospitalization for gastrointestinal complications related to peptic ulcers with bleeding or perforation: comparison of two national databases. Am J Manag Care 1998;4: s3, 399-409.
55. Darouiche, R. O. Deviceassociated infections: a macroproblem that starts with microadherence. Clin Infect Dis 2001;33: s9, 1567-1572.
56. Klevens, R. M., Edwards, J. R., Richards, C. L. Jr. et al. Estimating health care-associated infections and deaths in U. S. hospitals, 2002. Public Health Rep 2007;122: s2, 160-166.
57. Tambyah, P. A., Knasinski, V, Maki, D. G. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 2002;23: s1, 27-31.
58. von Eiff, C., Jansen, B., Kohnen, W,. Becker, K. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs 2005;65: s2, 179-214.
59. Kidney and Urologic Diseases Statistics for the United States. National Kidney and Urologic Diseases Information Clearinghouse 2007 May [cited 2007 Aug. 30];Available from: URL:http://kidney.niddk.nih.gov/kudiseases/pubs/kustats/ index.htm#up
60. Parsek, M. R., Singh, P. K. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 2003;57:677-701.
61. Coe, F. L., Evan, A., Worcester, E. Kidney stone disease. J Clin Invest 2005;115: s10, 2598-608.
62. Allsworth, J. E., Peipert, J. F. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007;109: s1, 114-120.
63. Hillier, S. L., Nugent, R. P., Eschenbach, D. A. et al. Association between bacterial vaginosis and preterm delivery of a lowbirth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med 1995;333: s26, 1737-1742.
64. MacDorman, M. F., Callaghan, W. M., Mathews, T. J. et al. Trends in Preterm-Related Infant Mortality by Race and Ethnicity: United States, 1999-2004. Centers for Disease Control and Prevention 2007 May 21 Available from: URL:http://www.cdc.gov/nchs/products/pubs/pubd/hestats/infantmort99-04/ infantmort99-04.htm
65. Martin, J. A., Hamilton, B. E., Sutton, P. D. et al. Births: Final Data for 2004. National Vital Statistics Reports 2006 September 29 [cited 2007 Aug. 30]; 55, s1
66. McGregor, J. A., French, J. I. Bacterial vaginosis and preterm birth. N Engl J Med 1996;334: s20, 1337-1338.
67. McGregor, J. A., French, J. I. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 2000;55:5 Suppl. s1, S1-19.
68. Swidsinski A, Mendling W, Loening-Baucke V, et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol 2005;106: (5 Pt 1), 1013-1023.
69. Calhoun, E. A., McNaughton, C. M., Pontari, M. A. et al. The economic impact of chronic prostatitis. Arch Intern Med 2004;164: s11, 1231-1236.
70. Clemens, J. Q., Meenan, R. T., O'keeffe Rosetti, M. C. et al. Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses. J Urol. 2007;178(4 Pt 1):1333-1337.
71. Domingue, G. J., Sr., Hellstrom, W. J. Prostatitis. Clin Microbiol Rev 1998;11: s4, 604-613.
72. Espinoza, J., Goncalves, L. F., Romero, R. et al. The prevalence and clinical significance of amniotic fluid 'sludge' in patients with preterm labor and intact membranes. Ultrasound Obstet Gynecol 2005;25: s4, 346-352.
73. Kusanovic, J. P., Espinoza, J., Romero, R. et al. Clinical significance of the presence of amniotic fluid 'sludge' in asymptomatic patients at high risk for spontaneous preterm delivery. Ultrasound Obstet Gynecol 2007.
74. Russell, R. B., Green, N. S., Steiner, C. A. et al. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics 2007;120: s1, e1-e9.
75. File, T. M., Jr. Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. Am J Med 2004;117: Suppl 3A, 39S-50S.
76. Oggioni, M. R., Trappetti, C., Kadioglu, A. et al. Switch from planktonic to sessile life: a major event in pneumococcal pathogenesis. Mol Microbiol 2006;61: s5, 1196-1210.
77. Morbidity & Mortality: 2007 Chart Book on Cardiovascular, Lung, and Blood Diseases. http://wwwnhlbinihgov/resources/docs/cht-bookhtm 2007 [cited 2007 Aug. 31];
78. Alamoudi, O. S. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study. Respirology 2007;12: s2, 283-287.
79. Eldika, N., Sethi, S. Role of nontypeable Haemophilus influenzae in exacerbations and progression of chronic obstructive pulmonary disease. Curr Opin Pulm Med 2006;12: s2, 118-124. (Pubitemid 44384786)
80. Lin, S. H., Kuo, P. H., Hsueh, P. R. et al. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology 2007;12: s1, 81-7.
81. Murphy, T. F., Kirkham, C. Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili. BMC Microbiol 2002;2: s7.
82. Starner, T. D., Zhang, N., Kim, G. et al. Haemophilus influenzae forms biofilms on airway epithelia: implications in cystic fibrosis. Am J Respi r Crit Care Med 2006;174: s2, 213-220.
83. Yamazaki, Y., Danelishvili, L., Wu, M. et al. The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells. Cell Microbiol 2006;8: s5, 806-814.
84. Rosamond, W., Flegal, K., Friday, G. et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115: s5, e69-171.
85. Chua, J. D., Wilkoff, BL, Lee I, et al. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med 2000;133: s8, 604-608.
86. Darouiche, R. O. Treatment of infections associated with surgical implants. N Engl J Med 2004;350: s14, 1422-9.
87. Blot, S. I., Depuydt, P., Annemans, L. et al. Clinical and economic outcomes in critically ill patients with nosocomial catheterrelated bloodstream infections. Clin Infect Dis 2005;41: s11, 1591-1598.
88. Maki, D. G., Kluger, D. M., Crnich, C. J. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006;81: s9, 1159-1171.
89. Pittet, D., Tarara, D., Wenzel, R. P. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271: s20, 1598-1601.
90. Cheng, K. H., Leung, S. L., Hoekman, H. W. et al. Incidence of contact-lensassociated microbial keratitis and its related morbidity. Lancet 1999;354: s9174, 181-185.
91. Keay, L., Edwards, K., Naduvilath, T., Forde K, Stapleton F. Factors affecting the morbidity of contact lens-related microbial keratitis: a population study. Invest Ophthalmol Vis Sci 2006;47: s10, 4302-4308.
92. Poggio, E. C., Glynn, R. J., Schein, O. D. et al. The incidence of ulcerative keratitis among users of daily-wear and extendedwear soft contact lenses. N Engl J Med 1989;321: s12, 779-783.
93. Zegans, M. E., Becker, H. I., Budzik, J,. O'Toole, G. The role of bacterial biofilms in ocular infections. DNA Cell Biol 2002;21: s5-6, 415-420.
94. Kodjikian, L., Burillon, C., Roques, C. et al. Intraocular lenses, bacterial adhesion and endophthalmitis prevention: a review. Biomed Mater Eng 2004;14: s4, 395-409.
95. Schmier, J. K., Halpern, M. T., Covert, D. W. et al. Evaluation of Medicare costs of endophthalmitis among patients after cataract surgery. Ophthalmology 2007;114: s6, 1094-1099.
96. Bondy, J., Berman, S., Glazner, J., Lezotte, D. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric medicaid cohort. Pediatrics 2000;105: s6, E72.
97. Ehrlich, G. D., Veeh, R., Wang, X. et al. Mucosal biofilm formation on middle-ear mucosa in the chinchilla model of otitis media. JAMA 2002;287: s13, 1710-1715.
98. Hall-Stoodley, L., Hu, F. Z., Gieseke, A. et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006;296: s2, 202-211.
99. Costerton, W., Veeh, R., Shirtliff, M. et al. The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 2003;112: s10, 1466-1477.
100. Coticchia, J., Zuliani, G., Coleman, C. et al. Biofilm surface area in the pediatric nasopharynx: Chronic rhinosinusitis vs obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 2007;133; s2, 110-114.
101. Murphy, M. P., Fishman, P., Short, S. O. et al. Health care utilization and cost among adults with chronic rhinosinusitis enrolled in a health maintenance organization. Otolaryngol Head Neck Surg 2002;127: s5, 367-376.
102. Psaltis, A. J., Ha, K. R., Beule, A. G. et al. Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis. Laryngoscope 2007;117: s7, 1302-1306.
103. Sanclement, J. A., Webster, P., Thomas, J., Ramadan, HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope 2005;115: s4, 578-82.
104. Fact Sheet: Trauma, Shock, Burn, and Injury: Facts and Figures. National Institute of General Medical Sciences 2007. Available from: URL:http://www. nigms.nih.gov/Publications/trauma-burn-facts.htm
105. Agnihotri, N., Gupta, V., Joshi, R. M. Aerobic bacterial isolates from burn wound infections and their antibiograms-a fiveyear study. Burns 2004;30: s3, 241-243.
106. Armour, A. D., Shankowsky, H. A., Swanson, T., Lee J, Tredget EE. The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit. J Trauma 2007;63: s1, 164-171.
107. Church, D., Elsayed, S., Reid, O. et al. Burn wound infections. Clin Microbiol Rev 2006;19: s2, 403-434.
108. Beckrich, K., Aronovitch, S. A. Hospitalacquired pressure ulcers: a comparison of costs in medical vs. surgical patients. Nurs Econ 1999;17: s5, 263-271.
109. Beitz, J. M. Overcoming barriers to quality wound care: a systems perspective. Ostomy Wound Manage 2001;47: s3, 56-64.
110. Landi, F., Onder, G., Russo, A., Bernabei, R. Pressure ulcer and mortality in frail elderly people living in community. Arch Gerontol Geriatr 2007;44(Suppl 1), 217-223.
111. Medina, A., Scott, P. G., Ghahary, A., Tredget, E. E. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil 2005;26: s4, 306-319.
112. Perencevich, E. N., Sands, K. E., Cosgrove, S. E. et al. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis 2003;9: s2, 196-203.
113. National Diabetes Statistics. National Diabetes Information Clearinghouse 2005 January 9 NIH Publication No. 06-3892 Available from: URL:http://diabetes. niddk.nih.gov/dm/pubs/statistics/index.htm#7
114. Boyko, E. J., Ahroni, J. H., Smith, D. G., Davignon, D. Increased mortality associated with diabetic foot ulcer. Diabet Med 1996;13: s11, 967-972.
115. Davis, S. C., Martinez, L., Kirsner, R. The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep 2006;6: s6, 439-445.
116. Ngo, Q., Vickery, K., Deva, A. K. Pr21 role of bacterial biofilms in chronic wounds. ANZ J Surg 2007;77: (Suppl 1) A66.
117. Ramsey, S. D., Newton, K., Blough, D. et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 1999;22: s3, 382-387.
118. Tice, A. D., Hoaglund, P. A., Shoultz, D. A. Risk factors and treatment outcomes in osteomyelitis. J Antimicrob Chemother 2003;51: s5, 1261-1268.
119. Partanen, J., Syrjala, H., Vahanikkila, H., Jalovaara, P. Impact of deep infection after hip fracture surgery on function and mortality. J Hosp Infect 2006;62: s1, 44-59.
120. Pollard, T. C., Newman, J. E., Barlow, N. J. et al. Deep wound infection after proximal femoral fracture: consequences and costs. J Hosp Infect 2006;63: s2, 133-139.
121. Wolcott, R. D., Kennedy, J. P., Dowd, S. E. Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care 2009;18: s2, 54-56..